Adeberg

Panel A: The weekly Gravitrap Aedes aegypti index (GAI), which measures the abundance of adult A. aegypti mosquitoes, in the intervention and control clusters before and during the release of wolbachia-infected male mosquitoes. Panel B: A spatial visualization of the intervention (red) and control (teal) clusters.

In this report from Singapore, the release of wolbachia-infected, irradiated male 𝘈𝘦𝘥𝘦𝘴 𝘢𝘦𝘨𝘺𝘱𝘵𝘪 mosquitoes resulted in a reduction in the vector population and in the risk of dengue infection. Full report: nej.md/4atd2iN

#MedSky #IDSky

Phase III trial: Proton therapy (IMPT) is non-inferior to IMRT in oropharyngeal cancer, with better overall survival and significantly less tox, while maintaining similar disease control. ➡️ Supports IMPT

www.thelancet.com/journals/lan...

@thelancet.com @astro-org.bsky.social
#oncology #medicine

Clinical Practice Complex Regional Pain Syndrome An illustration of the symptoms and signs of complex regional pain syndrome in the affected limb. The NEJM identity sits at the bottom.

A new review summarizes the diagnosis and treatment of complex regional pain syndrome, a rare limb-pain disorder. Early rehabilitation and multidisciplinary care are key; most patients improve within 18 months. Read the Clinical Practice article: nej.md/3MSMW0n

@liverpooluni.bsky.social #MedSky

Found this gem from 1919 in our Department Library - #RadOnc Marburg 📚🩻

A dissertation “Die Behandlung der #Malaria mit X-Rays” (Berlin, 1919) — a fascinating window into the early history of #radiology after #WorldWar I.⭐️
@astro-org.bsky.social
@hmpxvt.bsky.social
@ascocancer.bsky.social

Not Otherwise Specified Episode 3.4 If You Break It, They Won’t Come

In the latest episode of the Not Otherwise Specified podcast, host Lisa Rosenbaum, MD, and her guests explore the fraught relationship between medical training and primary care — and why even trainees who once aspired to be PCPs are changing course midstream.  

#MedSky

11.3.2025 - Score to Settle Podcast Episode · QuadShot News Podcast · 11/03/2025 · 8m

The latest podcast episode from our #ACROpolis partners at QuadShot News highlights the role of elective nodal treatment in bladder cancer, the impact of cribriform morphology on prostate cancer metastasis risk, and much more: podcasts.apple.com/us/podcast/1...

Conclusion:

ESMO–ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitors The combination of radiotherapy (RT) with targeted agents or immunotherapy may result in improved outcomes, but it can also increase toxicity. However, there is a paucity of high-quality toxicity data...

⚡️& 🧪: Combinig RT with IO?

👉ESMO–ESTRO consensus statements on the safety of combining radiotherapy with IO, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitors (TKI)

www.annalsofoncology.org/article/S092...

@myesmo.bsky.social @astro-org.bsky.social

#healthcare #cancerresearch

ESMO–ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitors The combination of radiotherapy (RT) with targeted agents or immunotherapy may result in improved outcomes, but it can also increase toxicity. However, there is a paucity of high-quality toxicity data...

⚡️& 🧪: Combinig RT with IO?

👉ESMO–ESTRO consensus statements on the safety of combining radiotherapy with IO, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitors (TKI)

www.annalsofoncology.org/article/S092...

@myesmo.bsky.social @astro-org.bsky.social

#healthcare #cancerresearch

Diagram explaining uveitis, an eye inflammation. It shows eye anatomy, uveitis types (anterior, intermediate, posterior, panuveitis), associated symptoms like redness and pain, and treatments including antibiotics and steroid eye drops. Untreated uveitis may cause vision loss.

Uveitis is a condition involving inflammation in the uvea (the middle portion of the eye).

📝 This JAMA Patient Page describes types of uveitis, ages and conditions associated with uveitis, and diagnosis and treatment.

ja.ma/48TW7a4

Original Article | Oct 30, 2025 A Randomized Trial of Physical Therapy for Meniscal Tear and Knee Pain Figure 1. Adjusted Mean KOOS Pain Subscores over Time. The NEJM identity sits at the bottom.

In the TeMPO trial, reduction in knee pain at 3 months was similar in participants assigned to home exercise alone and those assigned to home exercise, motivational text messages, and standard physical therapy. Full trial results: nej.md/4ofjqQt

#MedSky #Rheumatology

💪🏻 strong

American Society for Radiation Oncology (ASTRO) marks President Biden’s treatment milestone, highlighting #radiationtherapy’s vital role in prostate #cancer care 🎯

www.astro.org/news-and-pub...

#healthcare #oncology #radonc

@ascocancer.bsky.social @myesmo.bsky.social

A bar chart of the distribution of rare disease categories in the U.K. Biobank cohort.

Analyses of U.K. Biobank and clinical cohorts show that rare genetic diseases can be misdiagnosed as common diseases, which may have implications for clinical trials as well as for diagnosis and treatment. Full study results: nej.md/3Jk1MvD

#MedSky #Genetics

Incredible - 34thousand participants in Berlin💪🏻

#ESMO25: 177Lu-PSMA-617 with ADT plus ARPI showed PFS benefit in hormone-sensitive #ProstateCancer (#HSPC) but no improvement seen with 177Lu-PSMA-617 vs docetaxel in castration-resistant prostate cancer (#mCRPC) after ARPI.
#ESMODailyReporter ➡️ https://ow.ly/2C0e50XeAoj

📈Great Posters: EURO-ACT study atlas & ACCEPT program for Lung cancer patients

#ESMO2025 #ProstateCancer #NSCLC #RadiationOncology #Immunotherapy #ClinicalTrials

🫁 SKYSCRAPER-03 (Stage III NSCLC): Atezo+tira fails to beat durva after cCRT → durvalumab remains #standard.

MDT-BRIDGE (neo-IO NSCLC): High resection (85.7%) and R0 rates with close MDT guidance → more patients reach curative local #therapy.

#radonc Highlights from the last 24 hours at ESMO #Berlin 🚀

🌰ENZARAD (high-risk PCa): No overall MFS benefit with ENZA, but clear gains in cN1 & pelvic-RT subgroups.Selective intensification may matter

EMBARK (hrBCR PCa): Enza + ADT cuts mortality risk by ~40% vs ADT alone → a new standard of care

Figure. Addition of local consolidative therapy to osimertinib improved PFS versus osimertinib alone in patients with EGFR-mutated metastatic NSCLC in the NorthStar trial (ESMO Congress 2025, LBA72)

👇NorthStar trial - #ESMO highlight 17.10.

🧠 LCT improved PFS across subgroups
🌐 Even with >3 mets (20.7 vs 15.9 mo)
🧬 EGFR ex19del: 39.8 vs 22.8 mo
🔬 L858Rmut: 19.1 vs 11.0 mo
💪 Comprehensive vs partial LCT: 33.1 vs 15.1 mo

dailyreporter.esmo.org

@myesmo.bsky.social @astro-org.bsky.social

It was a pleasure to welcome the Nursing Directorate of Asklepios 👩‍⚕️👨‍⚕️ to our MIT - Marburg Ion-beam Therapy Center @ukgm.bsky.social 🏥!

Thx for the open discussions and the practical perspectives with a clear focus on #patientcare 💙.

#Healthcare #Collaboration #Innovation #HealthCareManagement

🌿 Science, collaboration & inspiration at Castle Rauischholzhausen 🏰 At the #ADMIT Summer School we explored medical physics & RT, shared ideas across disciplines & returned with fresh energy ✨ #Oncology #MedicalPhysics #Innovation

@ukgm.bsky.social @physics.bsky.social @unimarburg.bsky.social

#glioblastoma #steroids #mri | Sebastian Adeberg Very insightful! #glioblastoma #steroids #mri

www.linkedin.com/posts/prof-d...

👉 My Key Takeaway:
Old process + expensive tech = expensive old process.

True progress needs smart redesign – not just digital tools, but digitally enabled workflows.

#DigitalHealth #Collaboration

@unimarburg.bsky.social @asklepiosgarden.bsky.social

Impressions of DEGRO 2025

Meeting friend of the #radonc #family!

With 43 talks and posters from doctoral students to group leaders we had a busy schedule💪🏻

#Team #Marburg
#oncology

Science Feed Rules: 🧪 No misinformation 🧪 Keep posts relevant to science 🧪 Use alt text 🧪 Credit images 🧪 Give context to links to external sites 🧪 Have fun!

Welcome to the Science feed!

Please read our FAQs for instructions for how to be added as a contributor: bossett.io/science-feed/

Mod introductory posts linked below⬇️

Use the test tube emoji on posts you want to appear in the feed🧪

Please like the feed and make sure you follow our feed rules:

Very interesting Cosima! #AI guided decision-making in boards is going to be the near #future🦾

We are already using it at Need.com when generating interdisciplinary treatment recommendations for #cancer patients📊

Careful #human supervision is still necessary🧐

pubmed.ncbi.nlm.nih.gov/40281318/

🔥Dose-escalation studies in prostate cancer:

Studies with escalated external beam radiotherapy, targeting the whole prostate gland, showed improved bcFS, MFS and OS

📈Overview on FLAME trials (2021) Hypofx regimens were not mentioned as standard at that time.

#radonc #urology #healthcare